Skip to main content

CORRECTION article

Front. Oncol., 02 June 2020
Sec. Cancer Molecular Targets and Therapeutics
Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.00889

Corrigendum: HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells

This article is a correction to:

  1. HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells

    1. Read original article
\nYarely M. Salinas-VeraYarely M. Salinas-Vera1Dolores Gallardo-RincnDolores Gallardo-Rincón2Raúl García-VzquezRaúl García-Vázquez3Olga N. Hernndez-de la CruzOlga N. Hernández-de la Cruz1Laurence A. MarchatLaurence A. Marchat3Juan Antonio Gonzlez-BarriosJuan Antonio González-Barrios4Erika Ruíz-GarcíaErika Ruíz-García2Carlos Vzquez-CalzadaCarlos Vázquez-Calzada5Estefanía Contreras-SanznEstefanía Contreras-Sanzón1Martha Resendiz-HernndezMartha Resendiz-Hernández1Horacio Astudillo-de la VegaHoracio Astudillo-de la Vega6Jos L. Cruz-ColinJosé L. Cruz-Colin7Alma D. Campos-ParraAlma D. Campos-Parra8Csar Lpez-Camarillo César López-Camarillo1*
  • 1Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de Mexico, Mexico City, Mexico
  • 2Laboratorio de Medicina Translacional y Departamento de Tumores Gastro-Intestinales, Instituto Nacional de Cancerología, Mexico City, Mexico
  • 3Programa en Biomedicina Molecular y Red de Biotecnología, Instituto Politécnico Nacional, Mexico City, Mexico
  • 4Laboratorio de Medicina Genómica, Hospital Regional 1 de Octubre ISSSTE, Mexico City, Mexico
  • 5Departamento de Infectómica y Patogénesis Molecular, CINVESTAV-IPN, Mexico City, Mexico
  • 6Laboratorio de Investigación Translacional en Cáncer y Terapia Celular, Hospital de Oncología, Centro Médico Nacional Siglo XXI, Mexico City, Mexico
  • 7Subdirección de Investigación Básica, Instituto Nacional de Medicina Genómica, Mexico City, Mexico
  • 8Laboratorio de Genómica, Instituto Nacional de Cancerología, Mexico City, Mexico

A Corrigendum on
HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells

by Salinas-Vera, Y. M., Gallardo-Rincón, D., García-Vázquez, R., Hernández-de la Cruz, O. N., Marchat, L. A., González-Barrios, J. A., et al. (2019). Front. Oncol. 9:381. doi: 10.3389/fonc.2019.00381

In the original article there was a mistake in the title. This article deals with “miR-765” and not “miR-745.” The correct title is above.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: ovarian cancer, vasculogenic mimicry, hypoxia, miR-765, VEGFA

Citation: Salinas-Vera YM, Gallardo-Rincón D, García-Vázquez R, Hernández-de la Cruz ON, Marchat LA, González-Barrios JA, Ruíz-García E, Vázquez-Calzada C, Contreras-Sanzón E, Resendiz-Hernández M, Astudillo-de la Vega H, Cruz-Colin JL, Campos-Parra AD and López-Camarillo C (2020) Corrigendum: HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells. Front. Oncol. 10:889. doi: 10.3389/fonc.2020.00889

Received: 29 April 2020; Accepted: 05 May 2020;
Published: 02 June 2020.

Edited and reviewed by: Monica Venere, The Ohio State University, United States

Copyright © 2020 Salinas-Vera, Gallardo-Rincón, García-Vázquez, Hernández-de la Cruz, Marchat, González-Barrios, Ruíz-García, Vázquez-Calzada, Contreras-Sanzón, Resendiz-Hernández, Astudillo-de la Vega, Cruz-Colin, Campos-Parra and López-Camarillo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: César López-Camarillo, Z2Vub21pY2FzJiN4MDAwNDA7eWFob28uY29tLm14

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.